GVD ±R Regimen for Autologous Hematopoietic Stem Cell Transplantation(ASCT)-Eligible Patients With Refractory/Replapsed Diffuse Large B-cell Lymphoma
Condition: Lymphoma, Large B-Cell, Diffuse Intervention: Drug: gemcitabine, vinorelbine and doxorubicin liposome, with or without rituximab Sponsor: Sun Yat-sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials